Stockscreener 앱 받기
1.365
1.09%
-0.015
시간 외 거래:
1.38
0.015
+1.10%
전일 마감가:
$1.38
열려 있는:
$1.38
하루 거래량:
82,204
Relative Volume:
0.03
시가총액:
$5.33M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-13.06%
1개월 성능:
-28.53%
6개월 성능:
-96.58%
1년 성능:
-98.44%
1일 변동 폭
$1.36
$1.44
1주일 범위
$1.35
$1.59
52주 변동 폭
$1.21
$323.25
Psyence Biomedical Ltd Stock (PBM) Company Profile
PBM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
1.365 | 5.33M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.32 | 120.86B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 77.62B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.62B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.20B | 3.30B | -501.07M | 1.03B | -2.1146 |
Psyence Biomedical Ltd 주식(PBM)의 최신 뉴스
Psyence Biomedical Ltd (PBM) Stock: A Value Analysis - The News Heater
Ratio Analysis: Unpacking Psyence Biomedical Ltd (PBM)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Psyence Biomedical Adjusts Financials for Reverse Stock Split - TipRanks
Short Interest in Psyence Biomedical Ltd. (NASDAQ:PBMWW) Decreases By 41.0% - Defense World
Psyence enters into $25M common stock purchase agreement with White Lion Capital - MSN
Psyence Biomedical Issues Pre-Funded Share Purchase Warrant - TipRanks
Psyence Biomed Announces Closing of $2.0 Million Private Placement - The Manila Times
Psyence Biomed (PBM) Raises $2M in Private Placement with Warrant Coverage, Led by H.C. Wainwright - StockTitan
Psyence Biomedical Regains Nasdaq Compliance, Fortifying Market Position - Yahoo Finance
Psyence Biomed announces $2 million private placement By Investing.com - Investing.com Nigeria
PBMPsyence Biomedical Ltd. Common Shares Latest Stock News & Market Updates - StockTitan
Psyence Unveils Private Placement - Baystreet.ca
Psyence Biomed announces $2 million private placement - Investing.com
Psyence Biomed Announces $2.0 Million Private Placement - The Manila Times
Psyence Biomed Secures $2M Private Placement with Strategic Warrant Offering - StockTitan
Psyence Biomedical Achieves Full Nasdaq Compliance, Advances Clinical Trial Plans with $5.6M War Chest - StockTitan
Financial Genius or Just Lucky? Psyence Biomedical Defies Nasdaq Odds! - Jomfruland.net
US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone' - Benzinga
US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone' - Benzinga
Psyence Biomedical Signs Exclusive Licensing Agreement with Optimi Health - TipRanks
Psyence Biomedical Advances in Phase IIb Psilocybin Clinical Trial - TipRanks
Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial - The Manila Times
Optimi Health to Supply GMP-Certified Psilocybin for Psyence Biomed's Phase IIb Palliative Care Trial - Newsfile
Psyence Biomedical executes binding agreements with Optimi Health - Yahoo Finance
Psyence Biomedical stock soars on binding agreements with Optimi Health - MSN
Psyence Biomed Executes Binding Agreements with Optimi Health Corp - Marketscreener.com
Psyence Biomed Executes Binding Agreements with Optimi Health Corp. - The Manila Times
Psyence Biomed Secures Landmark Global Psilocybin Supply Deal for Palliative Care Drug Development - StockTitan
Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations - The Manila Times
Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle - EIN News
Why Verint Systems Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket - Benzinga
Psyence Biomedical Boosts Equity to Meet Nasdaq Rules - TipRanks
Psyence Biomedical Revises Debt-for-Equity Deal - TipRanks
Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress By Investing.com - Investing.com Canada
Psyence Biomed Strengthens Position with Valuable Stake and Trials - TipRanks
Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress - The Manila Times
Psyence Biomedical issues letter to shareholders - TipRanks
Psyence Biomedical Ltd trading halted, news pending - TipRanks
Psyence Biomed granted Nasdaq listing extension By Investing.com - Investing.com Australia
Psyence Biomedical Secures Extension To Meet Nasdaq Compliance Standards - Benzinga
Psyence Biomedical to consolidate shares in bid to keep Nasdaq listing - Green Market Report
Psyence Biomedical gets extension to show compliance with Nasdaq’s listing rules - MSN
Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing - The Manila Times
Psyence Biomed granted Nasdaq listing extension - Investing.com
Psyence Biomedical Announces Favorable Result Of Nasdaq Listing Qualifications Hearing - XM
Psyence Biomedical Secures Nasdaq Extension, Plans 1-for-75 Share Consolidation | PBM Stock News - StockTitan
Psyence Biomedical fell on 75-to-1 share consolidation and Nasdaq delisting notice - MSN
Psyence Biomedical Ltd (PBM) 재무 분석
Psyence Biomedical Ltd (PBM)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.03%
자본화:
|
볼륨(24시간):